Cargando…
Breaking barriers: NEK2 inhibition shines in multiple myeloma treatment
In their article, Cheng et al.(1) reveal that NEK2 loss reshapes the tumor microenvironment, reducing tumor-associated macrophages and decreasing T cell exhaustion. They show that this ultimately favors the immune system’s anti-cancer response in multiple myeloma.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591060/ https://www.ncbi.nlm.nih.gov/pubmed/37852178 http://dx.doi.org/10.1016/j.xcrm.2023.101237 |